High SHAP values for urinary protein or markedly reduced PlGF—identified as the strongest contributors in the model—may flag patients at imminent risk of placental abruption, suggesting the need for intensified maternal–fetal monitoring, earlier initiation of corticosteroids for fetal lung maturation, and closer evaluation for possible expedited delivery. This evidence concerns the gene PGF and placental abruption.